Is ocular toxoplasmosis caused by prenatal or postnatal infection?

British Journal of Ophthalmology

Volumn 84, Issue 2, 2000, Pages 224-226

  Gilbert, Ruth E ^a   Stanford, Miles R ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CLINICAL FEATURE; EYE INFECTION; HUMAN; INFANT; INTRAUTERINE INFECTION; NEWBORN; NOTE; ONSET AGE; PERINATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK; SEROLOGY; TOXOPLASMOSIS;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; RISK FACTORS; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR;

EID: 0034101532     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.2.224     Document Type: Note

References (33)

1. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57:1-17.
2. Burnett A, Shortt S, Isacc-Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998;105: 1032-7.
3. Holland GN, Engstrom RE Jr. Ocular toxoplasmosis in the United States. In: Belfort R, Petrilli A, Nussenblatt R, eds. World uveitis symposium. Sao Paulo: Roca, 1988:315-22.
4. Remington JS, McLeod R, Desmonts G. In: Remington JS, Klein J, eds. Infectious diseases of the fetus and newborn. Pennsylvania: WB Saunders, 1995;4:140-267.
5. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol 1993;77: 371-7.
6. Brezin A, Cisneros B. Congenital and acquired infection in ocular toxoplasmosis. Invest Ophthalmol Vis Sci 1999;40:S383.
7. Miettenen. Incidence of uveitis in Northern Finland. Acta Ophthalmol 1977; 55:252-60.
8. Wakefield D, Dunlop I, McCluskey PJ, et al. Uveitis: aetiology and disease associations in an Australian population. Aust NZ J Ophthalmol 1986;14:181-7.
9. Paivonsalo Hietanen T, Tuominen J, Vaahtoranta Lehtonen H, et al. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand 1997;75:76-81.
10. Secchi A, Tagnan S, Salmaso M, et al. Uveitis in Italy: 10 years of experience in a referral centre. In: Ohno S, Aoki K, Usui M, Uchio E, eds. Uveitis today. Amsterdam: Elsevier Science, 1998:232-8.
11. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;81:481-93.
12. Gilbert RE, Dunn D, Lightman S, et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999;123:283-9.
13. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group [see comments]. N Engl J Med 1994;330:1858-63.
14. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7.
15. Conyn-van-Spaedonck MAE. Prevention of congenital toxoplasmosis in the Netherlands (Thesis). Netherlands: National Institute of Public Health and Environmental Protection, 1991.
16. Lappalainen M, Koskiniemi M, Hiilesmaa V, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J 1995;14:354-61.
17. Koppe JG, Loewer Sieger DH, de Roever Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986;i:254-6.
18. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996;122:309-24.
19. Peyron F, Wallon M, Bernardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis [letter]. N Engl J Med 1996;334:993-4.
20. Couvreur J, Desmonts G, Aron-Rosa D. Le prognostic oculaire de la toxoplasmose congenitale: role du traitement: communication preliminaire. Ann Pediatr Paris 1984;31:855-8.
21. Couvreur J, Thulliez P. [Acquired toxoplasmosis of ocular or neurologic site: 49 cases]. Presse Med 1996;25:438-42.
22. Leblanc A, Bamberger J, Guillien F, et al. [Acquired toxoplasmic chorioretinitis with a late onset]. Arch Fr Pediatr 1985;42:37-9.
23. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol 1993;77: 371-7.
24. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol 1993;137:1022-34.
25. Glasner PD, Silveira C, Kruszon Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992;114:136-44.
26. Bosch Driessen EH, Rothova A. Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 1999;128:421-5.
27. Sibalic D, Djurkovic Djakovic O, Bobic B. Onset of ocular complications in congenital toxoplasmosis associated with immunoglobulin M antibodies to Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 1990;9:671-4.
28. Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol 1996;80:956-61.
29. Belfort R, Silveira C, Muccioli C, et al. Incidence of acquired ocular toxoplasmosis seroconversion and clinical course in a prospective study (7 year follow-up). Invest Ophthalmol Vis Sci 1999;40:S383.
30. Berger R, Merkel S, Rudin C. [Toxoplasmosis and pregnancy - findings from umbilical cord blood screening in 30,000 newborn infants]. Schweiz Med Wochenschr 1995;125:1168-73.
31. Ancelle T, Goulet V, Tirard-Fleury V, et al. La toxoplasmose chez la femme enceinte en France en 1995. Resultats d'une enquete nationale perinatale. Bull Epidemiol Hebdom 1996;51:227-9.
32. Dunn D, Wallon M, Peyron F, et al. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353: 1829-33.
33. Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999;128:502-5.